ESR1 and breast adenocarcinoma: The appropriateness of this model for human carcinoma cells was tested using the parental MDA-MB-231 estrogen receptor negative breast adenocarcinoma cell line [38] and a bone-seeking clonal line produced from these cells known as MDA-MB-231 BO [29].